Savara Investors File Class Action Lawsuit Over Securities Fraud.

Rosen Law Firm has filed a class action lawsuit against Savara Inc. (NASDAQ: SVRA) on behalf of investors who purchased securities between March 7, 2024, and May 23, 2025. The lawsuit alleges misrepresentations by the company during the class period. Those who purchased Savara securities during this time may be entitled to compensation through a contingency fee arrangement. To join the class action, visit https://rosenlegal.com/submit-form/?case_id=44874 or call Phillip Kim, Esq. at 866-767-3653.

Rosen Law Firm has filed a class action lawsuit against Savara Inc. (NASDAQ: SVRA) on behalf of investors who purchased securities between March 7, 2024, and May 23, 2025. The lawsuit alleges that the company made misrepresentations during the class period, which resulted in financial losses for investors.

According to the complaint, Savara Inc. made false and/or misleading statements and/or failed to disclose material adverse facts about its business, operations, and prospects. Specifically, the lawsuit alleges that Savara Inc. failed to disclose that the MOLBREEVI Biologics License Application (BLA) lacked sufficient information regarding its chemistry, manufacturing, and/or controls, making it unlikely that the FDA would approve the BLA in its current form. This delay increased the likelihood that Savara Inc. would need to raise additional capital, leading to misleading statements about the company's prospects Rosen Law Firm Urges Savara Inc. (NASDAQ: SVRA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights^[2].

Investors who purchased or otherwise acquired Savara securities during the Class Period may be eligible to participate in the class action lawsuit. Those who wish to join the class action can visit the Rosen Law Firm's website at https://rosenlegal.com/submit-form/?case_id=44874 or contact attorney Phillip Kim, Esq. at 866-767-3653.

The deadline for investors to file a lead plaintiff motion with the court is November 7, 2025. Investors do not have to serve as lead plaintiffs to be eligible for a recovery. Rosen Law Firm represents investors in class actions on a contingency fee basis, meaning investors pay no fees or expenses unless the firm is successful in recovering damages Rosen Law Firm Urges Savara Inc. (NASDAQ: SVRA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights^[2].